BIE — Bioera SpA Income Statement
0.000.00%
Last trade - 00:00
- €1.38m
- €4.17m
- €1.60m
R2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28 | 11.8 | 1.19 | 4.67 | 1.6 |
Cost of Revenue | |||||
Gross Profit | 10.9 | 5.1 | 0.832 | 2.23 | 0.932 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 33 | 16.8 | -14.7 | 9.49 | 4.88 |
Operating Profit | -5.01 | -5.02 | 15.9 | -4.82 | -3.28 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.99 | -6.08 | 15.3 | -5.43 | -3.51 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.38 | -6.3 | 15.3 | -5.46 | -3.51 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.97 | -2.75 | 15.5 | -5.46 | -3.51 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.97 | -2.75 | 15.5 | -5.46 | -3.51 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.05 | -2.72 | -1.08 | -1.28 | -0.154 |
Dividends per Share |